OLIPOP’s gutsy play to dethrone Coke and Pepsi, with Ben Goodwin

Episode Summary

Executive Summary: Bob Safian interviews Olipop co-founder/CEO/formulator Ben Goodwin about building one of the fastest-growing beverage brands while navigating intense competition from Pepsi and Coke. Goodwin argues Olipop is a genuinely healthy soda backed by clinical research, and explains how product quality, authentic marketing, and leadership maturation—not just hype—drive sustainable scale.

Main Topics: Olipop’s origin and the role of the formulator-CEO (Priority: 5/5): Goodwin explains that he still leads flavor development and sees himself as a formulator first, CEO second. He frames formulation as his most direct creative connection to consumers and a key driver of product quality. What functional soda is and why it matters (Priority: 5/5): The conversation traces soda’s history and the rise of diet soda, then positions functional soda as a new category built around fiber, prebiotics, and digestive health rather than just reduced sugar or artificial sweeteners. Health claims, science, and product credibility (Priority: 5/5): Goodwin defends Olipop’s health positioning by citing in vitro and human clinical work with Purdue, including microbiome, digestive, and blood sugar stability research. He contrasts this with competitors he sees as trend-chasing. Competition, validation, and exit optionality (Priority: 4/5): The hosts discuss Pepsi’s acquisition of Poppi and Coke’s launch of Simply Pop. Goodwin says big-brand entry validates the category, while Olipop preserves optionality through possible M&A or an IPO. Marketing, authenticity, and celebrity relationships (Priority: 4/5): Goodwin describes Olipop’s social strategy as organic and customer-led, with many non-professional creators. He emphasizes that celebrity partnerships only work when they feel authentic, using Camila Cabello as the strongest example. Scaling pains and leadership development (Priority: 5/5): A major theme is the psychological and organizational strain of extreme growth. Goodwin reflects on becoming a systems engineer, learning emotional maturity, and recognizing that he can be either a company unlock or bottleneck. Gratitude, burnout, and staying grounded (Priority: 3/5): Goodwin acknowledges the dream-like scale of Olipop’s success but also the burnout that can prevent him from enjoying milestones. He returns to formulation as a grounding practice and source of joy.

Key Arguments: Olipop is not just a prebiotic soda; it is a functional soda built around a broader nutritional philosophy of fiber, prebiotics, and nutritional diversity. Goodwin argues Olipop is actually healthy, pointing to Purdue lab partnerships, in vitro trials, and a pilot human study showing stable blood sugar for three hours. Big soda companies entering the category validates the market opportunity rather than threatening the category’s legitimacy. Authentic, product-driven growth is more durable than purely marketing-driven growth; Olipop benefits from organic demand and word of mouth. As companies scale, founders must evolve from hands-on builders into systems engineers who manage people, structures, and emotional maturity. Leadership is as much about interpersonal and emotional development as strategy; Goodwin suggests this is under-discussed relative to MBAs and business frameworks. Formulation remains central to Olipop’s identity because product quality is the foundation for customer trust and brand affinity.

Data Points: Growth rate: 960% in 2020 - Goodwin cites Olipop’s explosive year-over-year growth as an example of the company’s rapid scaling. Revenue increase: $200 million to $500 million in one year - Bob Safian references the company’s dramatic revenue jump during the interview. Funding valuation: around $2 billion - Olipop recently raised funds at an approximately $2 billion valuation. Market size: $60 billion - Goodwin describes the U.S. soda market as a massive category Olipop aims to transform. Household penetration: 98% - He cites soda’s near-universal presence in U.S. households as evidence of the category’s scale. Retail footprint: 52,000 retail locations - Olipop’s distribution reach is discussed as part of its mainstream success. Starbucks footprint: over 12,000 outlets - Bob notes Olipop’s presence in Starbucks locations. Household reach: one out of five households - Bob frames Olipop’s consumer penetration as a major brand milestone. Job applications: about 400,000 - Goodwin says Olipop received nearly 400,000 applications in a year, compared with 84,000 the prior year. Headcount: about 210 employees - Goodwin states the company’s current size while discussing hiring demand. Research setting: Purdue - Olipop’s clinical and stability work is described as being done through partnerships at Purdue. Blood sugar study duration: 3 hours - Goodwin says the pilot human clinical trial kept blood sugar stable for a full three hours. Acquisition price of rival: just under $2 billion - Bob mentions PepsiCo’s acquisition of Poppi at a price near Olipop’s valuation. Super Bowl ad spend: $16 million - Bob references Poppi’s one-minute Super Bowl spot as a high-cost marketing example. Content creator mix: 70% not professional influencers - Goodwin says most of Olipop’s social media creators are first-time creators rather than influencers.

Pivotal Quotes: "I will either be the one of the bigger unlocks for this company or I will be the biggest bottleneck." — Ben Goodwin: On the pressure of leadership during extreme growth and his responsibility as CEO. "We've been growing triple digits every single year." — Ben Goodwin: Describing Olipop’s sustained rapid expansion and the pace of the company’s scale-up. "Olipop is actually healthy." — Ben Goodwin: His direct response to skepticism about functional soda and health claims.

Implications: The episode suggests the healthy-beverage boom is real, but durable winners will need credible science, authentic branding, and founder leadership that evolves with scale. For consumers, it raises the bar on what “healthy” should mean; for startups, it shows growth requires emotional as well as operational maturity.